The risk of myocardial infarction in patients with and without atherosclerosis is best predicted by the number of apolipoprotein B (apoB)-containing lipoproteins, and this risk is independent from the ...
The “dose-response” relationships that apolipoprotein B (apoB) and LDL cholesterol have with coronary artery disease, all-cause mortality, and cardiovascular mortality do not appear to have lower ...
ApoB is emerging as a crucial piece of the heart health puzzle, even as sophisticated machines whir and beep with promises of precise diagnoses in the gleaming corridors of modern medicine. As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback